Envirotainer, the specialist in temperature-sensitive pharmaceutical shipments, has been awarded the “Most Numerous Vary of Packaging” award at Cool Chain Unbroken 2024. This recognition highlights the firm’s dedication to delivering official packaging alternatives for all levels of the pharmaceutical lifecycle and across all alternate segments.
The award shows the rising need for more versatile and efficient frosty chain alternatives as the build a query to for transporting high-cost, temperature-sensitive medications continues to rise. Having built-in va-Q-tec’s developed passive cooling alternatives into its possess sharp resolution portfolio, Envirotainer now enables pharmaceutical companies to transport merchandise at any temperature and stage of the product lifecycle, whether or no longer for medical trials, sharp pharmaceutical ingredients (APIs), or carried out medicines for industrial relate.
From shrimp-scale shipments to increased industrial portions, Envirotainer’s alternatives are designed to retain staunch temperatures over prolonged intervals. This endurance helps sensitive pharmaceuticals, including precision medicines, developed cell and gene therapies, vaccines, and therapies for persistent ailments, safely attain patients in far-off and no longer easy locations.
“This recognition shows our dedication to providing alternatives that abet all patients, irrespective of where they are, originate access to existence-saving medicines and therapies,” acknowledged Jonathon Haydn-Evans, Head of Sales, APAC.
“Pharmaceutical companies face more difficult challenges than ever, with the rising build a query to for numerous medications and the must attain patients in far-off regions. We toughen them by providing staunch, temperature-controlled alternatives that aid a truly noteworthy medicines safe, even in no longer easy conditions.”
Envirotainer’s intensive global network, combined with the largest rapid in the alternate, enables pharmaceutical companies to conquer advanced logistical challenges. With alternatives available when mandatory, this lets in faster access to temperature-controlled packaging, serving to reveal extreme therapies to patients with out delays.
